Read more

June 17, 2023
2 min read
Save

Post-cycle therapy may help former anabolic steroid users recover testosterone levels

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

CHICAGO — Men who stop using anabolic-androgenic steroids may be able to restore their testosterone with the use of post-cycle therapy drugs, according to data presented at ENDO 2023.

In findings from an audit of data from a clinic in Scotland, men who discontinued anabolic-androgenic steroid use had higher mean testosterone if they used post-cycle therapy drugs such as human chorionic gonadotropins, selective estrogen receptor modulators and aromatase inhibitors, compared with men not using post-cycle drugs, with greater odds for testosterone normalization observed in men who used fewer steroids and used steroids for a shorter period of time.

Post-cycle therapy linked to higher biochemical response in former anabolic steroid users
Data were derived from Jayasena CN. Abstract OR25. Presented at: ENDO Annual Meeting; June 15-18, 2023; Chicago.

“When men stop steroids, you get a crash in testosterone levels, which produces awful symptoms,” Channa Jayasena, MD, PhD, a reproductive endocrinologist at Imperial College London, said during a press conference. “Men are actually self-treating themselves with drugs to stimulate the testes, which is not recommended. [However], they have a fourfold higher chance ... to prevent hypogonadism.”

Channa Jayasena

Researchers conducted a clinical audit of 613 men who discontinued use of anabolic-androgenic steroids in Scotland from 2015 to 2022 at a single addiction service clinic. Participants underwent a random blood test within 12 months of discontinuing use. The cohort was split into a group that used post-cycle therapy drugs and those who did not use post-cycle therapy drugs. Biochemical response was defined as a combination of reference range levels of total testosterone, serum luteinizing hormone and serum follicle-stimulating hormone as a marker for biochemical recovery from hypogonadism.

Of the cohort, 76% reported post-cycle therapy drug use. Men who used post-cycle therapy drugs had a higher mean total testosterone than men who did not use post-cycle therapy drugs (12.8 nmol/L vs. 11.3 nmol/L; P = .024). Normalized hormone levels were achieved in 48% of men using post-cycle therapy drugs compared with 38% of those who did not (P = .04). Men in the post-cycle therapy group achieved normalized hormone levels at 13.3 weeks after stopping steroids compared with 18.7 weeks for those who did not use post-cycle therapy (P < .01).

Jayasena noted biochemical recovery of hormones was significant only for men who used post-cycle therapy and had used steroids for less than 3 months. Use of only one post-cycle therapy drug and post-cycle therapy duration of longer than 6 months were also associated with a greater likelihood of biochemical recovery.

During a Q&A session, Jayasena said the men taking post-cycle therapy were using a variety of different drugs and some men were not sure what they were taking.

“We’re not there in terms of recommending this, because there’s no causality,” Jayasena said.

Jayasena said a forensic investigation should be conducted to study the mechanistic effects of post-cycle therapy and how it could be made safe for men who previously used anabolic-androgenic steroids.